Minimally invasive surgical instruments market to reach $38.3B by 2025 due to spine surgery demands

Written by Mackenzie Garrity | February 05, 2019 | Print  |

The global minimally invasive surgical instruments market is predicted to exceed $38.3 billion by 2025, increasing at a 9.7 percent compound annual growth rate, according to a Grand View Research report.

Five things to know:

1. In 2017, handheld instruments led the device segment. However, electrosurgical devices are expected to experience the fastest CAGR during the forecast period.

2. Orthopedics led the application segment in terms of revenue share in 2017 due to easy surgical alternatives with minimum tissue disruption in the form of MIS procedures.

3. The continuous and rapid adoption of MIS techniques for spine-related procedures has led to the expansion of procedural volumes for orthopedic MIS.

4. North America held the majority of the market share in 2017 due to the presence of supportive reimbursement framework for innovative MIS devices and procedures.

5. Key market players include Medtronic, Abbott Laboratories, NuVasive, Stryker, Smith & Nephew, Zimmer Biomet and Intuitive Surgical.

More articles on devices and implants:
Orthofix acquires Options Medical: 3 things to know
Spinal surgical robots market to exceed $380M by 2024 with 33.6% CAGR: 4 details
Corin Group names new president: 5 takeaways

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months